Pei‐Jer Chen

1979–2026 年に発表

別表記
Pei-Jer Chen
274
論文数
43,174
被引用数
109
h 指数
260
i10 指数

被引用数

Pei‐Jer Chen の年別被引用数1979 年: 被引用 2 件1982 年: 被引用 1 件1987 年: 被引用 2 件1988 年: 被引用 7 件1989 年: 被引用 8 件1990 年: 被引用 10 件1991 年: 被引用 17 件1992 年: 被引用 27 件1993 年: 被引用 36 件1994 年: 被引用 39 件1995 年: 被引用 36 件1996 年: 被引用 23 件1997 年: 被引用 37 件1998 年: 被引用 50 件1999 年: 被引用 50 件2000 年: 被引用 57 件2001 年: 被引用 82 件2002 年: 被引用 108 件2003 年: 被引用 112 件2004 年: 被引用 153 件2005 年: 被引用 185 件2006 年: 被引用 178 件2007 年: 被引用 241 件2008 年: 被引用 214 件2009 年: 被引用 239 件2010 年: 被引用 270 件2011 年: 被引用 301 件2012 年: 被引用 392 件2013 年: 被引用 337 件2014 年: 被引用 401 件2015 年: 被引用 455 件2016 年: 被引用 346 件2017 年: 被引用 381 件2018 年: 被引用 333 件2019 年: 被引用 1,172 件2020 年: 被引用 1,575 件2021 年: 被引用 1,424 件2022 年: 被引用 928 件2023 年: 被引用 708 件2024 年: 被引用 1,109 件2025 年: 被引用 561 件2026 年: 被引用 11 件1980〜1981 年は被引用が無いため表示していません1983〜1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,917 件、この内訳の 18.8%中国: 引用元論文 2,727 件、この内訳の 17.5%台湾: 引用元論文 1,050 件、この内訳の 6.8%日本: 引用元論文 732 件、この内訳の 4.7%イタリア: 引用元論文 674 件、この内訳の 4.3%イギリス: 引用元論文 630 件、この内訳の 4%ドイツ: 引用元論文 560 件、この内訳の 3.6%フランス: 引用元論文 558 件、この内訳の 3.6%韓国: 引用元論文 555 件、この内訳の 3.6%香港: 引用元論文 446 件、この内訳の 2.9%カナダ: 引用元論文 408 件、この内訳の 2.6%オーストラリア: 引用元論文 375 件、この内訳の 2.4%
0%18.8%その他 25.2%

分野

  • Medicine75.8%
  • Biochemistry, Genetics and Molecular Biology15.2%
  • Immunology and Microbiology2.9%
  • Computer Science0.9%
  • Neuroscience0.8%
  • Agricultural and Biological Sciences0.8%
  • その他3.6%

トピック

  • Hepatitis B Virus Studies11.3%
  • Hepatitis C virus research9.5%
  • Liver Disease Diagnosis and Treatment9%
  • Hepatocellular Carcinoma Treatment and Prognosis8%
  • Hepatitis Viruses Studies and Epidemiology2.4%
  • SARS-CoV-2 and COVID-19 Research2%
  • その他57.8%

共著者

全論文

検索で開く
  1. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

    著者: , , , , , , , , , , , , , , , , , , , , - Hepatology International 2017 被引用: 2,179

  2. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Man‐Fung Yuen, Shu Zheng, Jia‐Horng Kao - Hepatology International 2015 被引用: 2,564

  3. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

    著者: , , , , , , , , , , - Liver International 2015 被引用: 1,256

  4. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amarsanaa Jazag, Motswedi Anderson, Monique Andersson, Paige Armstrong, Tarik Asselah, Kostas Athanasakis, Oidov Baatarkhuu, Ziv Ben‐Ari, Aïcha Bensalem, Fernando Bessone, Mia Biondi, Abdul Rahman Bizri, Sarah Blach, Wornei Silva Miranda Braga, Carlos Eduardo Brandão‐Mello, Carol Brosgart, Kimberly Brown, Robert Brown, Jr, Philip Bruggmann, Maurizia Brunetto, Maria Buti, Joaquin Cabezas, Teresa Casanovas, Chungman Chae, Henry Lik Yuen Chan, Hugo Cheinquer, Pei-Jer Chen, Kent Jason Cheng, Myeong-Eun Cheon, Cheng-Hung Chien, Gourdas Choudhuri, Peer Brehm Christensen, Wan-Long Chuang, Vladimir Chulanov, Laura Cisneros, Carla Coffin, Fernando Contreras, Nicola Coppola, Markus Cornberg, Benjamin Cowie, Matthew Cramp, Antonio Craxi, Javier Crespo, Fuqiang Cui, Chris Cunningham, Olav Dalgard, Robert De Knegt, Victor De Ledinghen, Gregory Dore, Sylvia Drazilova, Ann-Sofi Duberg, Steve Egeonu, Mohammed Elbadri, Mohamed El-Kassas, Manal El-Sayed, Chris Estes, Ohad Etzion, Elmobashar Farag, Laurent Ferradini, Paulo Ferreira, Robert Flisiak, Xavier Forns, Sona Frankova, James Fung, Edward Gane, Virginia Garcia, Javier García-Samaniego, Manik Gemilyan, Jordan Genov, Liliana Gheorghe ほか 169 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 404

  5. Treatment of Liver Cancer

    著者: , , - Cold Spring Harbor Perspectives in Medicine 2015 被引用: 386

  6. Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription

    著者: , , - Cell Host & Microbe 2014 被引用: 236

  7. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

    著者: , , , , , , , , , - The Lancet Oncology 2011 被引用: 660

  8. High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

    著者: , , , , , , , , , , - Gastroenterology 2012 被引用: 580

  9. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects

    著者: , , , , , , , , , , , , , , , , - Cell Reports 2020 被引用: 275

  10. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Berg, Mia J. Biondi, Wornei Silva Miranda Braga, Carlos Eduardo Brandão‐Mello, Robert S. Brown, Maurizia Rossana Brunetto, Joaquín Cabezas, Mariana Cardoso, Alexandra Martins, Henry Lik‐Yuen Chan, Hugo Cheinquer, C.-J. Chen, Hwai‐I Yang, Pei‐Jer Chen, Cheng‐Hung Chien, Wan‐Long Chuang, L. Cisneros Garza, B. Coco, Carla S. Coffin, Nicola Coppola, Markus Cornberg, Antonio Craxı̀, Javier Crespo, Liri Çuko, Victor de Lédinghen, A.‐S. Duberg, Ohad Etzion, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Xavier Forns, Graham R. Foster, James Fung, Giovanni Battista Gaeta, Javier García‐Samaniego, J Genov, Liliana Gheorghe, Patrick Gholam, Robert G. Gish, Jeffrey S. Glenn, Saeed Hamid, Julian Hercun, Yao‐Chun Hsu, Chih-Chien Hu, Jee‐Fu Huang, Ramazan Idılman, Wasim Jafri, Naveed Z. Janjua, Deian Jelev, Jidong Jia, Martin Kåberg, Kelly Kaita, Jia‐Horng Kao, Aamir Khan, Do Young ‍Kim, Loreta A. Kondili, Martin Lagging, Pietro Lampertico, Pablo Lázaro, Jeffrey V. Lazarus, M.-H. Lee, Hwai‐I Yang, Young‐Suk Lim, Cirley Lobato, Guilherme Macedo, Rui Tato Marinho, Paul Marotta, Maria Cássia Mendes-Corrêa, Nahúm Méndez‐Sánchez, M.-C. Navas, Qing Ning ほか 42 名 - Journal of Hepatology 2023 被引用: 95

  11. Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC

    著者: , , , , , , - Cellular and Molecular Gastroenterology and Hepatology 2023 被引用: 81

  12. Hepatitis B virus DNA integration: Implications for diagnostics, therapy, and outcome

    著者: , , , , - Journal of Hepatology 2024 被引用: 95

  13. Glycogen Synthase Kinase-3 Regulates the Phosphorylation of Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein and Viral Replication

    著者: , , , , , , , , , - Journal of Biological Chemistry 2008 被引用: 219

  14. Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 635

  15. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B

    著者: , , , , , , , , , , , , - Hepatology International 2023 被引用: 58

  16. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota

    著者: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 被引用: 209

  17. Cell‐Free Virus‐Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer

    著者: , , , , , , , , , , , - Hepatology 2020 被引用: 63

  18. Impaired glymphatic drainage underlying obstructive sleep apnea is associated with cognitive dysfunction

    著者: , , , , , , , , , , , , , , , , - Journal of Neurology 2023 被引用: 53

  19. Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liming Chen, Yuan-Tsong Chen, Chen‐Yang Shen - New England Journal of Medicine 2011 被引用: 694

  20. The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

    著者: , , , , , , , , , , , , , - Molecular Therapy — Nucleic Acids 2014 被引用: 377

  21. Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing

    著者: , , , , , , , , , , , - Molecular Therapy — Nucleic Acids 2020 被引用: 93

  22. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicola Coppola, Antonio Craxı̀, Javier Crespo, Victor de Lédinghen, Ann‐Sofi Duberg, Ohad Etzion, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Xavier Forns, Graham R. Foster, Giovanni Battista Gaeta, Ivane Gamkrelidze, Javier García‐Samaniego, Liliana Gheorghe, Pierre M. Gholam, Robert G. Gish, Jeffrey S. Glenn, Julian Hercun, Yao‐Chun Hsu, Ching‐Chih Hu, Jee‐Fu Huang, Naveed Z. Janjua, Jidong Jia, Martin Kåberg, Kelly Kaita, Habiba Kamal, Jia‐Horng Kao, Loreta A. Kondili, Martin Lagging, Pablo Lázaro, Jeffrey V. Lazarus, Mei‐Hsuan Lee, Young‐Suk Lim, Paul J. Marotta, María Cristina Navas, Marcelo Contardo Moscoso Naveira, Mauricio Orrego, Carla Osiowy, Calvin Q. Pan, Mário Guimarães Pessôa, Giovanni Raimondo, Alnoor Ramji, Devin Razavi‐Shearer, Kathryn Razavi‐Shearer, Cielo Ríos, Manuel Rodríguez, William Rosenberg, Dominique Roulot, Stephen Ryder, Rifaat Safadi, Faisal M. Sanai, Teresa Santantonio, Christoph Sarrazin, Daniel Shouval, Frank Tacke, Tammo Lambert Tergast, Juan Miguel Villalobos-Salcedo, Alexis Voeller, Hwai‐I Yang, Ming‐Lung Yu, Eli Zuckerman - Journal of Hepatology 2023 被引用: 61

  23. Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial

    著者: , , , , , , , , , , - Molecular Therapy 2023 被引用: 35

  24. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection

    著者: , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 被引用: 298